Diagnositics Players

ALL
News
Opinion
Photos
Videos

Jump to

SRL likely to be valued 25 times FY18 operating profit:Macquarie

Singhal sees significant opportunity for diagnositics players such as Dr Lal Path Labs, Thyrocare and SRL. Organised players are already gaining market share and companies which maintain quality standards will definitely do well, he says.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Diagnositics Players

SRL likely to be valued 25 times FY18 operating profit:Macquarie